Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy

NCT03724097 is registered in ClinicalTrials.gov with OmicsWay Corp. as lead sponsor.

NCT NCT03724097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03724097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy
Lead sponsor
OmicsWay Corp.
Phase
Observational
Overall status
Unknown status
Start date
October 17, 2017
Completion date
November 1, 2022
Enrollment
200 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cancer